E-LIB Suche - Ergebnisse für: Caillo, L

1

P927 Long-term outcomes of risankizumab in Crohn's disease:..:

Fumery, M ; Caron, B ; Hébuterne, X...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1686-i1686 , 2024

Link: https://doi.org/10.1093/..

2

P386 Persistence of bowel urgency despite clinical remissio..:

Buisson, A ; Amiot, A ; Nachury, M...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i812-i812 , 2024

Link: https://doi.org/10.1093/..

3

P679 Anti-TNF de-escalation following a treat-to-target str..:

Vuitton, L ; Poullenot, F ; Bouhnik, Y...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1290-i1290 , 2024

Link: https://doi.org/10.1093/..

4

P443 Risk of incident Cancer in Patients with Inflammatory ..:

Le Cosquer, G ; Gilletta, C ; Amiot, A...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i572-i572 , 2023

Link: https://doi.org/10.1093/..

5

P579 Real-world comparison of effectiveness between tofacit..:

Buisson, A ; Serrero, M ; Altwegg, R...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i707-i707 , 2023

Link: https://doi.org/10.1093/..

6

DOP89 Impact of biologics on the risk of early postoperativ..:

Fumery, M ; Nancey, S ; Nachury, M...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i166-i167 , 2023

Link: https://doi.org/10.1093/..

7

P604 Infection Risk in Elderly Patients with Inflammatory B..:

Bozon, A ; Serrero, M ; Caillo, L...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i537-i537 , 2022

Link: https://doi.org/10.1093/..

8

P207 COVID-19: a prevalence rate two times lower than that ..:

Lelong, M ; Nancey, S ; Bouguen, G...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i265-i266 , 2022

Link: https://doi.org/10.1093/..

9

How to Manage Inflammatory Bowel Disease Patients When They..:

Cottron, C ; Treton, X ; Altwegg, R...
Journal of Crohn's and Colitis. 16 (2022) 8 - p. 1202-1210 , 2022

Link: https://doi.org/10.1093/..

10

P558 Should we introduce early a new biological agent in pa..:

Cottron, C ; Treton, X ; Altwegg, R...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i502-i503 , 2022

Link: https://doi.org/10.1093/..

11

COMBIO : efficacité et tolérance des associations de thérap..:

Flachaire, B. ; Guillo, L. ; Avouac, J....
Revue du Rhumatisme. 88 (2021) - p. A52-A53 , 2021

Link: https://doi.org/10.1016/..

12

P355 Acceptability of treatment regimen in inflammatory bow..:

Buisson, A ; Fumery, M ; Serrero, M...
Journal of Crohn's and Colitis. 14 (2020) Supplement_1 - p. S337-S338 , 2020

Link: https://doi.org/10.1093/..

13

Dermatoses inflammatoires péri-orificielles, du cuir chevel..:

Schwob, E. ; Dunyach-Remy, C. ; Lavigne, J.-P....
Annales de Dermatologie et de Vénéréologie. 147 (2020) 12 - p. A144-A145 , 2020

Link: https://doi.org/10.1016/..

14

P248 Validation of IBD-disk for the assessment of daily-lif..:

Tadbiri, S ; Nachury, M ; Bouhnik, Y...
Journal of Crohn's and Colitis. 14 (2020) Supplement_1 - p. S272-S272 , 2020

Link: https://doi.org/10.1093/..

15

DOP74 Efficacy of ustekinumab in perianal Crohn's disease: ..:

Biron, C ; Seksik, P ; Nachury, M...
Journal of Crohn's and Colitis. 13 (2019) Supplement_1 - p. S074-S075 , 2019

Link: https://doi.org/10.1093/..